CSF Analysis in EGFR Mutant Non-Small Cell Lung Cancer With Leptomeningeal Disease

Clinical trial NCT05257967 · RECRUITING

Trial details

NCT number: NCT05257967
Sponsor: British Columbia Cancer Agency
Status: RECRUITING
Phase: Not Applicable
Study type: INTERVENTIONAL

EGFR Activating Mutation Leptomeningeal Metastasis Non Small Cell Lung Cancer

Start date: 2022-07-18
Primary completion: 2026-12-31
Enrollment: 10

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.